Eva Márquez

441 total citations
18 papers, 286 citations indexed

About

Eva Márquez is a scholar working on Nephrology, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Eva Márquez has authored 18 papers receiving a total of 286 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Nephrology, 5 papers in Molecular Biology and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Eva Márquez's work include Renal Diseases and Glomerulopathies (6 papers), Chronic Kidney Disease and Diabetes (5 papers) and Renin-Angiotensin System Studies (4 papers). Eva Márquez is often cited by papers focused on Renal Diseases and Glomerulopathies (6 papers), Chronic Kidney Disease and Diabetes (5 papers) and Renin-Angiotensin System Studies (4 papers). Eva Márquez collaborates with scholars based in Spain, United States and United Kingdom. Eva Márquez's co-authors include Julio Pascual, Marta Riera, María José Soler, Giuseppe Lanza, Alberto Paniz‐Mondolfi, Juan Luís Concepción, Javier Gimeno, Josep Lloreta, Daniel Batlle and Heleia Roca-Ho and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and Diabetologia.

In The Last Decade

Eva Márquez

16 papers receiving 283 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eva Márquez Spain 10 88 85 84 71 49 18 286
Gui Hua Wang China 10 39 0.4× 96 1.1× 154 1.8× 55 0.8× 75 1.5× 19 367
Heloísa Reniers Vianna Brazil 5 92 1.0× 50 0.6× 59 0.7× 50 0.7× 22 0.4× 9 209
G. Sansoè Italy 11 53 0.6× 55 0.6× 35 0.4× 60 0.8× 83 1.7× 32 298
Yoshinori Kakutani Japan 10 66 0.8× 24 0.3× 66 0.8× 50 0.7× 72 1.5× 21 297
Oruganti Sai Satish India 6 75 0.9× 20 0.2× 129 1.5× 70 1.0× 87 1.8× 30 411
Ron T. Gansevoort Netherlands 6 45 0.5× 80 0.9× 45 0.5× 32 0.5× 22 0.4× 17 233
Nikolaos Marketos Greece 6 21 0.2× 80 0.9× 78 0.9× 55 0.8× 41 0.8× 16 310
Rivka Lederman United States 11 25 0.3× 110 1.3× 141 1.7× 17 0.2× 32 0.7× 15 328
Eiichiro Satake Japan 10 24 0.3× 82 1.0× 159 1.9× 59 0.8× 24 0.5× 25 348
Jeng‐Yueh Hsiao Taiwan 14 46 0.5× 29 0.3× 85 1.0× 193 2.7× 74 1.5× 18 372

Countries citing papers authored by Eva Márquez

Since Specialization
Citations

This map shows the geographic impact of Eva Márquez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Márquez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Márquez more than expected).

Fields of papers citing papers by Eva Márquez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Márquez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Márquez. The network helps show where Eva Márquez may publish in the future.

Co-authorship network of co-authors of Eva Márquez

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Márquez. A scholar is included among the top collaborators of Eva Márquez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Márquez. Eva Márquez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Sierra, Adriana, Eva Rodríguez, Anna Faura, et al.. (2022). The GenoDiabMar Registry: A Collaborative Research Platform of Type 2 Diabetes Patients. Journal of Clinical Medicine. 11(5). 1431–1431. 3 indexed citations
2.
Lay, Abigail C., Lorna J. Hale, Robert J. P. Pope, et al.. (2021). IGFBP-1 expression is reduced in human type 2 diabetic glomeruli and modulates β1-integrin/FAK signalling in human podocytes. Diabetologia. 64(7). 1690–1702. 25 indexed citations
3.
Palau, Vanesa, Eva Márquez, Eva Rodríguez, et al.. (2021). Redefining the Role of ADAM17 in Renal Proximal Tubular Cells and Its Implications in an Obese Mouse Model of Pre-Diabetes. International Journal of Molecular Sciences. 22(23). 13093–13093. 4 indexed citations
4.
Gimeno, Javier, Laia Sans, Eva Márquez, et al.. (2021). Podocytopathy in patients with monoclonal gammopathy: three patients and literature review. Clinical Kidney Journal. 15(3). 417–424. 2 indexed citations
5.
Palau, Vanesa, Eva Márquez, Eva Rodríguez, et al.. (2021). Endothelial ADAM17 Expression in the Progression of Kidney Injury in an Obese Mouse Model of Pre-Diabetes. International Journal of Molecular Sciences. 23(1). 221–221. 4 indexed citations
6.
Santamaría, Beatriz, Eva Márquez, Abigail C. Lay, et al.. (2015). IRS2 and PTEN are key molecules in controlling insulin sensitivity in podocytes. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1853(12). 3224–3234. 27 indexed citations
7.
Márquez, Eva, et al.. (2015). Beneficios del descanso peritoneal. Enfermería Nefrológica. 18(3). 174–179.
8.
Riera, Marta, Eva Márquez, Javier Gimeno, et al.. (2014). Effect of Insulin on ACE2 Activity and Kidney Function in the Non-Obese Diabetic Mouse. PLoS ONE. 9(1). e84683–e84683. 43 indexed citations
9.
Márquez, Eva, Marta Riera, Julio Pascual, & María José Soler. (2014). Renin-angiotensin system within the diabetic podocyte. American Journal of Physiology-Renal Physiology. 308(1). F1–F10. 52 indexed citations
10.
Márquez, Eva, Marta Riera, Julio Pascual, & María José Soler. (2014). Albumin inhibits the insulin-mediated ACE2 increase in cultured podocytes. American Journal of Physiology-Renal Physiology. 306(11). F1327–F1334. 19 indexed citations
11.
Márquez, Eva, et al.. (2014). DI-058 Experience in paediatric use of dapsone for the treatment of linear IGA dermatosis. European Journal of Hospital Pharmacy. 21(Suppl 1). A93.2–A94.
12.
Riera, Marta, Eva Márquez, Javier Gimeno, et al.. (2014). Correction: Effect of Insulin on ACE2 Activity and Kidney Function in the Non-Obese Diabetic Mouse. PLoS ONE. 9(1). 7 indexed citations
13.
Márquez, Eva, Marta Crespo, Marisa Mir, et al.. (2013). Chagas' disease and kidney donation.. PubMed. 33(1). 128–33. 12 indexed citations
14.
Soler, María José, Marta Riera, Marta Crespo, et al.. (2012). Circulating Angiotensin-Converting Enzyme 2 Activity in Kidney Transplantation: A Longitudinal Pilot Study. Nephron Clinical Practice. 121(3-4). c144–c150. 24 indexed citations
15.
Márquez, Eva, Elizabeth A. Sadowski, Shannon R. Reese, et al.. (2012). Serum HSP27 is associated with medullary perfusion in kidney allografts. Journal of Nephrology. 25(6). 1075–1080. 9 indexed citations
16.
Montero, Núria, Clara Barrios, Eva Márquez, et al.. (2012). Correlation between the protein/creatinine ratio in spot urine and 24-hour urine protein.. PubMed. 32(4). 494–501. 15 indexed citations
17.
Divisón, J.A., et al.. (2010). Relationship between renal function and heart failure in hypertensive patients. Internal Medicine Journal. 40(1). 76–79. 2 indexed citations
18.
Paniz‐Mondolfi, Alberto, et al.. (2009). Amiodarone and Itraconazole: A Rational Therapeutic Approach for the Treatment of Chronic Chagas’ Disease. Chemotherapy. 55(4). 228–233. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026